Rising Pharmaceuticals launches and begins shipment of generic version of Lyrica in US
23 July 2019 -

Rising Pharmaceuticals, a Rising Pharma Holdings Inc company, has launched and started commercial shipment of a generic version of Lyrica, (pregabalin) Capsules in the United States, it was reported yesterday.

The product is available in eight commercially available strengths, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, & 300mg.

Pregabalin Capsules are indicated for management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, for adjunctive therapy for the treatment of partial onset seizures in patients four years of age and older, for the management of fibromyalgia, and for the management of neuropathic pain associated with spinal cord injury. The product should only be taken as prescribed.